| scholarly article | Q13442814 |
| P50 | author | Ulf Lindahl | Q5953253 |
| P2093 | author name string | Jalkanen M | |
| Salmivirta M | |||
| Kreuger J | |||
| Loo BM | |||
| P2860 | cites work | Structural basis for FGF receptor dimerization and activation | Q22010544 |
| Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity | Q22254157 | ||
| Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization | Q24290400 | ||
| Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin | Q24290496 | ||
| Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? | Q24561731 | ||
| Signal transduction by receptors with tyrosine kinase activity | Q27860624 | ||
| Production and characterization of the extracellular domain of recombinant human fibroblast growth factor receptor 4 | Q28139953 | ||
| Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase | Q28144405 | ||
| Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation | Q28296150 | ||
| Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
| Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity | Q32030968 | ||
| Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis | Q33902258 | ||
| Formation of anhydrosugars in the chemical depolymerization of heparin | Q34424006 | ||
| A strategy for rapid sequencing of heparan sulfate and heparin saccharides | Q35059120 | ||
| Proteoglycans: structures and interactions | Q37285263 | ||
| Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach | Q37461866 | ||
| The heparin-binding (fibroblast) growth factor family of proteins | Q38286731 | ||
| Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. | Q38302156 | ||
| Mode of interaction between platelet factor 4 and heparin | Q38318810 | ||
| Nature of the interaction of heparin with acidic fibroblast growth factor | Q38319104 | ||
| Sequence analysis of heparan sulphate and heparin oligosaccharides | Q38325522 | ||
| Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells | Q38331586 | ||
| Defining the interleukin-8-binding domain of heparan sulfate | Q38336349 | ||
| Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development | Q38339362 | ||
| Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain | Q38348282 | ||
| Copper and calcium binding motifs in the extracellular domains of fibroblast growth factor receptors | Q38361528 | ||
| The coordinated regulation of heparan sulfate, syndecans and cell behavior | Q40780342 | ||
| Structural diversity of N-sulfated heparan sulfate domains: distinct modes of glucuronyl C5 epimerization, iduronic acid 2-O-sulfation, and glucosamine 6-O-sulfation | Q40856219 | ||
| Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells | Q41281609 | ||
| Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin | Q42102840 | ||
| Identification of oversulphated galactosaminoglycans in intestinal-mucosal mast cells of rats infected with the nematode worm Nippostrongylus brasiliensis | Q42164055 | ||
| Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. | Q42834483 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1. | Q54174935 | ||
| Heparan Sulfate Proteoglycan Modulates Keratinocyte Growth Factor Signaling through Interaction with both Ligand and Receptor | Q58199738 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 16868-16876 | |
| P577 | publication date | 2001-02-21 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. | |
| P478 | volume | 276 |
| Q33230192 | 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. |
| Q21245645 | A heparin binding synthetic peptide from human HIP / RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparin |
| Q37809766 | Biology of FGFRL1, the fifth fibroblast growth factor receptor |
| Q31074211 | Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding |
| Q38331843 | Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor. |
| Q42801360 | Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs |
| Q38320039 | Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes |
| Q33897755 | Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains. |
| Q58377532 | Fibroblast Growth Factor Receptors 1 and 2 Interact Differently with Heparin/Heparan Sulfate |
| Q64258744 | Heparan Sulfate Sulfation by Hs2st Restricts Astroglial Precursor Somal Translocation in Developing Mouse Forebrain by a Non-Cell-Autonomous Mechanism |
| Q34989559 | Heparan sulfate fine structure and specificity of proteoglycan functions |
| Q104481994 | Heparan sulfate fine-tunes stromal-epithelial communication in the prostate gland |
| Q37590177 | Heparan sulfate proteoglycans: structure, protein interactions and cell signaling |
| Q38311931 | Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors |
| Q37132636 | Heparin accelerates gelsolin amyloidogenesis |
| Q38290891 | Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses |
| Q38418286 | Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. |
| Q28213553 | Hereditary multiple exostoses and heparan sulfate polymerization |
| Q38343318 | Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex. |
| Q33751398 | Is fibroblast growth factor receptor 4 a suitable target of cancer therapy? |
| Q38152204 | Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery |
| Q47143359 | More than a biomarker: the systemic consequences of heparan sulfate fragments released during endothelial surface layer degradation (2017 Grover Conference Series). |
| Q36851279 | Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells. |
| Q28475274 | Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases |
| Q46391304 | Novel heparan sulfate structures revealed by monoclonal antibodies |
| Q36219228 | Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo |
| Q45117201 | Polysialylated neural cell adhesion molecule promotes remodeling and formation of hippocampal synapses. |
| Q34361094 | Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function |
| Q24292847 | Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix |
| Q42193929 | Selective activation of TACI by syndecan-2 |
| Q43640409 | Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. |
| Q40601795 | Structural determinants of heparan sulphate modulation of GDNF signalling |
| Q34523315 | Structure and biological interactions of heparin and heparan sulfate |
| Q40630770 | Sulfated Derivatives of Escherichia coli K5 Polysaccharides as Modulators of Fibroblast Growth Factor Signaling |
| Q40668417 | The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex |
| Q39240834 | Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials |
Search more.